Latest Market Challenges News

Future Generation Australia has announced its tenth consecutive annual increase in fully franked interim dividends, driven by a strong 10.8% return on its investment portfolio over the past year.

Bapcor reports a softer FY25 with pro-forma NPAT of $81-82 million and statutory NPAT sharply lower at $31-34 million, citing operational disruptions and a challenging retail environment. The company also announces key board resignations amid a strategic reset.

Hiremii Limited reported a 4.4% revenue increase in Q4 FY25 alongside positive operating cash flow, while accelerating commercialisation of its proprietary AI recruitment platform and expanding through a key acquisition.

ReadCloud Limited reported a robust 35% increase in cash receipts for the June quarter, driven by strong growth in its VET-in-Schools segment and disciplined cost management. The company forecasts positive underlying EBITDA and operating cash flow for FY25, positioning itself for accelerated growth in 2026.

Bowen Coking Coal’s initial attempt to defer state royalty payments has been declined by the Queensland Revenue Office, prompting plans for a revised proposal amid ongoing debt restructuring efforts.

MOVE Logistics Group has achieved its FY25 financial targets, showcasing significant improvements in earnings and operational efficiency despite a tough economic backdrop in New Zealand.

Perpetual Limited reported a 2.5% increase in assets under management to A$226.8 billion for Q4 FY25, driven by strong market performance and inflows. The company reaffirmed its expense guidance and continues to pursue the sale of its Wealth Management business.

Genetic Signatures reported steady quarterly sales of $4.4 million, reflecting seasonal demand in Australia, while restructuring its US operations to accelerate growth. A new US contract and strategic partnerships signal potential for future expansion.

Volt Resources has drawn $0.5 million from a $1 million funding agreement to accelerate development of its graphite projects in Tanzania and the US, positioning itself amid rising US tariffs on Chinese graphite imports.

Future Generation Global has reported a robust 24.7% total shareholder return over 12 months alongside an increased fully franked interim dividend of 8.0 cents per share, underscoring its growing income stream.

EVE Health Group has secured regulatory approval enabling prescription access for its lead products Libbo and Dyspro in Australia, setting the stage for a commercial rollout before the end of 2025.

BKI Investment Company posted a solid financial performance for FY2025 with a 1% increase in dividends and introduced a neutralised Dividend Reinvestment Plan to maintain capital neutrality. Despite modest portfolio underperformance against major ETFs, BKI continues to offer an attractive dividend yield amid shifting market dynamics.